There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for SELLAS Life Sciences Group Inc. (SLS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.04, or 2.92%, to $1.41. The SELLAS Life Sciences Group Inc. has recorded 4,586 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that SELLAS Announces Publication of Positive GPS Clinical Data in Ovarian Cancer in Peer Reviewed Journal.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
As a NASDAQ listed company, SLS falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.37 and fluctuated between $1.4100 as its day high and $1.3100 as its day low. The current market capitalization of SELLAS Life Sciences Group Inc. is $39.20M. A total of 0.5 million shares were traded on the day, compared to an average of 389.74K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, SLS has seen 9 BUY and 0 SELL insider trades, representing the acquisition of 122,500 and the disposition of 0 shares. Over the last 12 months, there were 9 BUYs and 3 SELLs from insiders. Insiders purchased 122,500 shares during that period but sold 9,806.
In the most recent transaction, Stergiou Angelos M. sold 6,494 shares of SLS for 2.61 per share on Dec 05. After the transaction, the President and CEO now owns 161,689 company shares. In a previous transaction on Dec 05, WOOD BARBARA A sold 2,153 shares at 2.59 per share. SLS shares that EVP, Gen. Counsel, Corp. Sec. owns now total 56,344.
Among the insiders who sold shares, Burns John Thomas disposed of 1,159 shares on Dec 05 at a per-share price of $2.59. This resulted in the Senior VP, Finance & CAO holding 29,347 shares of SLS after the transaction.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for SLS in the last 3 months, the mean price target is $8.25 with high estimates of $12.00 and low estimates of $4.00. In terms of 52-week highs and lows, SLS has a high of $7.40 and a low of $1.39.
As of this writing, SLS has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.26 per share and a lower estimate of -$0.36. The company reported an EPS of -$0.41 in the last quarter, which was -17.10% lower than expectations of -$0.35.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLS is Buy with a score of 5.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.